[Commentary on] Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: an Eastern Cooperative Oncology Group Phase II Study (E2E93)

Title

[Commentary on] Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: an Eastern Cooperative Oncology Group Phase II Study (E2E93)

Creator

von Gruenigen V E

Publisher

Women's Oncology Review

Date

2001
2001-06

Subject

Female; Quality of Life; Disease Progression; Outpatients; Drug Therapy; Combination; Carboplatin; Carcinoma – Drug Therapy; Ovarian Neoplasms – Drug Therapy; Paclitaxel – Therapeutic Use

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Pages

149–150

Issue

2

Volume

1

Citation

von Gruenigen V E, “[Commentary on] Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: an Eastern Cooperative Oncology Group Phase II Study (E2E93),” NEOMED Bibliography Database, accessed June 22, 2021, https://neomed.omeka.net/items/show/6120.

Social Bookmarking